Answers are grounded in this paper and cite their sources.
SUMMARY Closed-loop clinical trials have resulted in significant advances with continuous glucose monitoring and control systems modulating insulin delivery. Those trials were performed in closely supervised clinical research settings; while adults with Type 1 diabetes were initially targeted, studies in children with Type 1 diabetes have followed in both clinical research units and pediatric diabetes camps. These studies have been conducted as multicenter and multinational efforts. Pediatric studies have since been piloted in home settings overnight for control during sleep. The stage is now set for accelerating efforts, extending the number of patients enrolled, the amount of time during which the system is active daily and the duration of the clinical trials.
No takes yet. Share an insight, caveat, or question.
Wadams et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: